Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

RNA-seq

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cells.

bioRxiv : the preprint server for biology·2026

Same author

Publisher Correction: Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 ribonucleoprotein.

Nature biotechnology·2026

Same author

Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin Shredding.

Nature·2026

Same author

Selective Elimination of TP53 Mutant Cells by Transcript-Activated Chromatin Shredding.

bioRxiv : the preprint server for biology·2026

Same author

Repeat multiplex PCR gastrointestinal panel testing within 14 days yields minimal additional diagnostic information: a multicenter cohort study.

Infection control and hospital epidemiology·2026

Same author

DUSP11 is an RNA triphosphatase that limits PspCas13b activity by destabilizing gRNA abundance in mammalian cells.

Nucleic acids research·2026

Same journal

Towards clinical-level interpretation of dental panoramic radiography using an instance-guided vision-language model.

Nature biomedical engineering·2026

Same journal

From breadth to depth in clinical artificial intelligence evaluation.

Nature biomedical engineering·2026

Same journal

Towards controllable self-amplifying RNA.

Nature biomedical engineering·2026

Same journal

Unaddressed implications of the FDA's 2026 guidance on wellness devices.

Nature biomedical engineering·2026

Same journal

Implementing trust in non-small cell lung cancer diagnosis with a conformalized uncertainty-aware AI framework.

Nature biomedical engineering·2026

Same journal

Engineering drug-responsive replication machinery for precise control of self-amplifying RNA.

Nature biomedical engineering·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 2, 2026

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Published on: August 16, 2024

Programmable kinetic barcoding for multiplexed RNA detection with Cas13a.

Sungmin Son^1,2, Amy Lyden^3,4, Carlos F Ng^3,4

¹Department of Bioengineering, University of California, Berkeley, CA, USA. smson@kaist.ac.kr.

Nature Biomedical Engineering

|March 31, 2026

Summary

This summary is machine-generated.

This study introduces a novel CRISPR-Cas13a method for rapid, multiplexed RNA detection. Kinetic barcoding allows differentiation of viruses and SARS-CoV-2 variants without DNA sequencing.

More Related Videos

Genetic Barcoding with Fluorescent Proteins for Multiplexed Applications

Genetic Barcoding with Fluorescent Proteins for Multiplexed Applications

Published on: April 14, 2015

Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging

Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging

Published on: December 8, 2023

Related Experiment Videos

Last Updated: Apr 2, 2026

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Published on: August 16, 2024

Genetic Barcoding with Fluorescent Proteins for Multiplexed Applications

Genetic Barcoding with Fluorescent Proteins for Multiplexed Applications

Published on: April 14, 2015

Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging

Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging

Published on: December 8, 2023

Area of Science:

Molecular Biology
Biotechnology
Infectious Disease Diagnostics

Background:

Accurate and rapid identification of viral infections and variants is crucial for public health.
Current methods like PCR require DNA amplification, while direct RNA detection assays (CRISPR-Cas13a) lack easy multiplexing capabilities.

Purpose of the Study:

To develop a multiplexed RNA detection method using CRISPR-Cas13a that avoids DNA sequencing.
To enable simultaneous detection of multiple viruses and specific SARS-CoV-2 variants from patient samples.

Main Methods:

Leveraged the variable nuclease activity of Cas13a based on target RNA-crRNA interactions.
Developed a crRNA modification strategy to program Cas13a's enzymatic rates for kinetic tuning.
Employed a droplet-based Cas13a assay to analyze kinetic signatures.

Main Results:

Demonstrated the ability to differentiate between various respiratory viruses and SARS-CoV-2 variants.
Successfully applied the kinetic barcoding strategy in both contrived and clinical samples.
Showcased the adaptability of the method for detecting additional RNA targets via crRNA modification.

Conclusions:

Kinetic barcoding using modified crRNAs offers a novel approach for multiplexed RNA detection with CRISPR-Cas13a.
This method provides a simple, rapid alternative to DNA sequencing for identifying viral infections and variants.
The strategy is versatile and can be extended to a broader range of RNA targets.